| |
| |
|
| Insider
Information: |
Monia Brett P |
| Relationship: |
Director |
| City: |
Carlsbad |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
180,289 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$6,788,557 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
180,289 |
|
|
| Total
Value |
$6,788,557 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
9
|
|
Stock
price went up :
|
0
|
2
|
| Stock
price went down : |
0
|
7
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -99.5%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Ionis Pharmaceuticals Inc |
IONS |
CEO Level 15, Director |
2024-02-29 |
174,289 |
2012-01-01 |
0 |
Premium* |
|
|
Cognition Therapeutics Inc |
CGTX |
Director |
2023-06-09 |
6,000 |
2023-06-09 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
116 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 5 of 5
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| IONS |
Ionis Pharmaceuticals Inc |
Chief Executive Officer |
• • – |
2023-12-14 |
4 |
S |
$49.21 |
$1,190,019 |
D/D |
(24,000) |
118,111 |
0 |
% |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chief Executive Officer |
• • – |
2023-02-06 |
4 |
S |
$40.69 |
$1,003,153 |
D/D |
(24,651) |
145,305 |
0 |
% |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chief Executive Officer |
• • – |
2023-01-18 |
4 |
S |
$39.49 |
$989,947 |
D/D |
(25,066) |
120,863 |
0 |
% |
|
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Drug Discovery |
• – – |
2014-08-26 |
4 |
OE |
$7.25 |
$253,267 |
D/D |
27,344 |
11,813 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Drug Discovery |
• – – |
2014-08-26 |
4 |
AS |
$38.14 |
$1,043,010 |
D/D |
(27,344) |
1,813 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chief Executive Officer |
• • – |
2024-01-17 |
4 |
S |
$50.42 |
$1,616,319 |
D/D |
(32,059) |
154,136 |
0 |
% |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chief Operating Officer |
• – – |
2018-11-23 |
4 |
OE |
$14.69 |
$499,460 |
D/D |
34,000 |
49,841 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chief Operating Officer |
• – – |
2018-11-23 |
4 |
AS |
$55.00 |
$1,870,058 |
D/D |
(34,000) |
15,841 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chief Executive Officer |
• • – |
2021-01-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
34,823 |
63,702 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chief Executive Officer |
• • – |
2024-02-01 |
4 |
A |
$0.00 |
$0 |
D/D |
45,788 |
197,639 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chief Executive Officer |
• • – |
2023-02-03 |
4 |
A |
$0.00 |
$0 |
D/D |
49,093 |
169,956 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chief Executive Officer |
• • – |
2022-01-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
49,475 |
99,944 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Drug Discovery |
• – – |
2013-09-19 |
4 |
AS |
$33.35 |
$1,679,700 |
D/D |
(50,000) |
769 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Drug Discovery |
• – – |
2013-09-19 |
4 |
OE |
$11.27 |
$737,400 |
D/D |
50,000 |
2,644 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chief Executive Officer |
• • – |
2023-01-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
57,267 |
145,929 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chief Executive Officer |
• • – |
2024-01-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
68,084 |
186,195 |
0 |
- |
|
116 Records found
|
|
Page 5 of 5 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
